Exousia Bio (LMMY) EBT Margin (2023 - 2024)
Exousia Bio (LMMY) posted EBT Margin of 104.29% for Q3 2024, up 25.55% sequentially from 140.08% in Q2 2024.
Powered by 
Analysis
Exousia Bio (LMMY) EBT Margin (2023 - 2024) Analysis & Trends
Exousia Bio (LMMY) has 2 years of EBT Margin data on file, last reported at 104.29% in Q3 2024.
- Quarterly EBT Margin changed N/A year-over-year to 104.29% in Q3 2024, while the trailing twelve-month figure through May 2025 was 3388.88% (up 361329.0% YoY) and the FY2025 annual result came in at 1370.53%, up 159494.0% from the prior year.
- EBT Margin improved to 104.29% in Q3 2024 per LMMY's latest filing, from 140.08% in the prior quarter.
- The five-year high for EBT Margin was 92.21% in Q4 2023, with the low at 140.08% in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | New Oriental Education & Technology | 94.41 Bn | 91.67 Bn | 812.22 Mn | 5.61% |
| 2 | Laureate Education | 5.12 Bn | 4.96 Bn | 237.67 Mn | 35.52% |
| 3 | Graham Holdings | 4.77 Bn | 3.52 Bn | 777.03 Mn | 24.37% |
| 4 | Covista | 4.52 Bn | 4.11 Bn | 284.63 Mn | 17.63% |
| 5 | Grand Canyon Education | 3.97 Bn | 3.70 Bn | 204.08 Mn | 23.05% |
| 6 | Stride | 3.66 Bn | 2.71 Bn | 217.28 Mn | 16.40% |
| 7 | McGraw Hill | 2.53 Bn | 2.33 Bn | 439.20 Mn | 12.46% |
| 8 | Perdoceo Education | 2.07 Bn | 768.24 Mn | 162.46 Mn | 28.22% |
| 9 | TAL Education | 1.94 Bn | -740.46 Mn | 227.32 Mn | 2.10% |
| 10 | Exousia Bio | 368,824.87 | 368,824.87 | -62,108.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2024 | -104.29% |
| May 31, 2024 | -140.08% |
| Feb 29, 2024 | -124.39% |
| Nov 30, 2023 | -92.21% |